• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在经皮机械循环支持下心源性休克患者中植入心脏再同步治疗设备

Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support.

作者信息

Lim Kyunghee, Choi Jin-Oh, Yang Jeong Hoon, Park Seung-Jung, Kim Sun Hwa, Kang Jiseok, Joh Hyun Sung, Shin Sun Hye

机构信息

Division of Cardiology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean Circ J. 2017 Jan;47(1):132-135. doi: 10.4070/kcj.2016.0176. Epub 2016 Dec 23.

DOI:10.4070/kcj.2016.0176
PMID:28154601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5287175/
Abstract

65-year-old woman was admitted to our hospital with acute decompensated heart failure with reduced left ventricular ejection fraction and severe mitral regurgitation. Electrocardiography revealed a typical left bundle branch block and atrial fibrillation. Her condition deteriorated despite administering high-doses of inotropes and vasopressors. Pending a decision to therapy, venoarterial extracorporeal membrane oxygenation (ECMO) was performed when the patient underwent a cardiogenic shock. Although the hemodynamic status stabilized with ECMO support, weaning the patient from ECMO was not possible. Thus, we decided to perform cardiac resynchronization with defibrillator implantation as a "rescue" therapy. Five days post-implantation, the patient was successfully weaned from ECMO.

摘要

一名65岁女性因急性失代偿性心力衰竭伴左心室射血分数降低和严重二尖瓣反流入住我院。心电图显示典型的左束支传导阻滞和心房颤动。尽管给予了大剂量的正性肌力药物和血管加压药,她的病情仍恶化。在决定治疗方案期间,当患者发生心源性休克时,进行了静脉-动脉体外膜肺氧合(ECMO)治疗。尽管在ECMO支持下血流动力学状态稳定,但患者无法脱离ECMO。因此,我们决定进行心脏再同步化并植入除颤器作为“挽救”治疗。植入后五天,患者成功脱离ECMO。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/51867f2eb01e/kcj-47-132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/2955fb5afa2b/kcj-47-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/3316e86939b1/kcj-47-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/51867f2eb01e/kcj-47-132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/2955fb5afa2b/kcj-47-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/3316e86939b1/kcj-47-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/5287175/51867f2eb01e/kcj-47-132-g003.jpg

相似文献

1
Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support.在经皮机械循环支持下心源性休克患者中植入心脏再同步治疗设备
Korean Circ J. 2017 Jan;47(1):132-135. doi: 10.4070/kcj.2016.0176. Epub 2016 Dec 23.
2
Percutaneous venoarterial extracorporeal membrane oxygenation as a bridge to double valve implantation in acute biventricular heart failure with profound cardiogenic shock.经皮静脉-动脉体外膜肺氧合作为急性双心室心力衰竭合并严重心源性休克患者双瓣膜置换术的过渡治疗手段
J Card Surg. 2019 Dec;34(12):1664-1666. doi: 10.1111/jocs.14255. Epub 2019 Sep 11.
3
Left Atrial Venoarterial Extracorporeal Membrane Oxygenation for Acute Aortic Regurgitation and Cardiogenic Shock.左心房静脉动脉体外膜肺氧合用于急性主动脉瓣反流和心源性休克
JACC Case Rep. 2022 Mar 2;4(5):276-279. doi: 10.1016/j.jaccas.2021.12.030.
4
Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock.体外膜肺氧合用于嗜铬细胞瘤诱发的心源性休克
Ann Intensive Care. 2016 Dec;6(1):117. doi: 10.1186/s13613-016-0219-4. Epub 2016 Nov 28.
5
Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients.体外膜肺氧合治疗心脏手术后难治性心源性休克:51 例成人患者早期死亡率和预后的预测因素。
Eur J Cardiothorac Surg. 2010 Feb;37(2):328-33. doi: 10.1016/j.ejcts.2009.07.033. Epub 2009 Sep 12.
6
Hemodynamics of cardiac tamponade during extracorporeal membrane oxygenation support in a patient with fulminant myocarditis.暴发性心肌炎患者体外膜肺氧合支持期间心脏压塞的血流动力学
J Cardiol Cases. 2018 Oct 25;19(1):22-24. doi: 10.1016/j.jccase.2018.08.009. eCollection 2019 Jan.
7
Acute Myocardial Infarction Complicated by Cardiogenic Shock: An Algorithm-Based Extracorporeal Membrane Oxygenation Program Can Improve Clinical Outcomes.急性心肌梗死合并心源性休克:基于算法的体外膜肺氧合程序可改善临床结局。
Artif Organs. 2016 Mar;40(3):261-9. doi: 10.1111/aor.12538. Epub 2015 Jul 6.
8
Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial.体外膜肺氧合在治疗心原性休克中的应用(ECMO-CS):多中心随机试验的原理和设计。
Eur J Heart Fail. 2017 May;19 Suppl 2:124-127. doi: 10.1002/ejhf.857.
9
VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.非手术难治性心源性休克患者的VA-ECMO支持:植入前结局预测因素
Artif Organs. 2019 Feb;43(2):132-141. doi: 10.1111/aor.13331. Epub 2018 Nov 6.
10
Extracorporeal membrane oxygenation in treatment of cardiogenic shock caused by acute myocarditis.体外膜肺氧合治疗急性心肌炎所致心源性休克
J Formos Med Assoc. 1998 May;97(5):364-6.

引用本文的文献

1
The ABCDE approach to difficult weaning from venoarterial extracorporeal membrane oxygenation.ABCDE 法在脱离静脉-动脉体外膜肺氧合中的应用
Crit Care. 2022 Jul 15;26(1):216. doi: 10.1186/s13054-022-04089-8.
2
Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion.心源性休克中的心脏再同步治疗:基于病例的讨论
Cureus. 2021 Sep 21;13(9):e18157. doi: 10.7759/cureus.18157. eCollection 2021 Sep.
3
Cardiac resynchronization therapy in New York Heart Association class-IV patients dependent on intravenous drugs or invasive supportive treatments.

本文引用的文献

1
Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator.
Korean J Thorac Cardiovasc Surg. 2015 Feb;48(1):55-8. doi: 10.5090/kjtcs.2015.48.1.55. Epub 2015 Feb 5.
2
Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotrope-dependent heart failure patients.心脏再同步治疗对终末期依赖血管活性药物的心衰患者的疗效
Kardiol Pol. 2014;72(9):777-82. doi: 10.5603/KP.a2014.0090. Epub 2014 May 20.
3
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
纽约心脏协会IV级患者中依赖静脉药物或侵入性支持治疗的心脏再同步治疗
ESC Heart Fail. 2020 Oct;7(5):3109-3118. doi: 10.1002/ehf2.12940. Epub 2020 Aug 13.
4
Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.伴有缓慢心室反应的心房颤动患者心脏再同步治疗的结果。
PLoS One. 2019 Jan 11;14(1):e0210603. doi: 10.1371/journal.pone.0210603. eCollection 2019.
Europace. 2013 Aug;15(8):1070-118. doi: 10.1093/europace/eut206. Epub 2013 Jun 24.
4
CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF.心脏再同步化治疗除颤器(CRT-D)在纽约心功能分级(NYHA)四级充血性心力衰竭(CHF)失代偿患者中的应用。
Cardiol Res Pract. 2012;2012:319205. doi: 10.1155/2012/319205. Epub 2012 Jul 30.
5
Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure.在一名终末期心力衰竭患者植入心脏再同步治疗设备后成功撤离体外膜肺氧合。
Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):922-3. doi: 10.1093/icvts/ivs338. Epub 2012 Jul 30.
6
Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction.心脏再同步治疗左心室收缩功能障碍危重症患者。
Int J Cardiol. 2013 Feb 20;163(2):141-5. doi: 10.1016/j.ijcard.2011.05.034. Epub 2011 Jun 12.
7
Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy.心脏再同步化治疗在需要正性肌力药物治疗的终末期心力衰竭患者中的作用。
J Card Fail. 2010 Dec;16(12):931-7. doi: 10.1016/j.cardfail.2010.07.253.
8
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.依伐布雷定治疗慢性心力衰竭的疗效评价(SHIFT):一项随机、安慰剂对照研究
Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1.
9
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
10
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies.心房颤动患者的心脏再同步治疗:前瞻性队列研究的荟萃分析
J Am Coll Cardiol. 2008 Oct 7;52(15):1239-46. doi: 10.1016/j.jacc.2008.06.043.